Concepedia

Wilman Luk

WL

Statistics

Publications

12

Citations

2.8K

H-Index

12

Active since

2011

Affiliations

PDL BioPharma (United States)(Current)

Research & Diagnostic Antibodies (United States)

Genesys (United States)

Atotech (United States)

Institute for Neurodegenerative Disorders

Wilman Luk is an author at PDL BioPharma (United States) specializing in therapeutic antibody delivery to the brain, neuroscience, and pharmacy.

Publications per year

2011–2021

12

Publications

12

Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target

Yichao Yu, Yin Zhang, Margaret Kenrick et al. · Science Translational Medicine · 2011 · 800 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates

Yang Yu, Jasvinder K. Atwal, Yin Zhang et al. · Science Translational Medicine · 2014 · 369 citations

Pharmacy, Neuroscience, Pharmacology +17

Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants

Nga Bien‐Ly, Yang Yu, Daniela Bumbaca et al. · The Journal of Experimental Medicine · 2014 · 353 citations · Full text

Pharmacy, Neuroscience, Pharmacology +17

Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies

Y. Joy Yu Zuchero, Xiaocheng Chen, Nga Bien‐Ly et al. · Neuron · 2015 · 292 citations · Full text

Pharmacy, Neuroscience, Pharmacology +16

A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo

Jasvinder K. Atwal, Yongmei Chen, Cecilia Chiu et al. · Science Translational Medicine · 2011 · 277 citations

Life Sciences, Neurobiology, Neuroscience +15

1–5 of 12